Journal profile · Urology & Nephrology
International Journal of Impotence Research
ISSN 0955-9930 · eISSN 1476-5489 · Springer Nature · ENGLAND · Bimonthly · Founded 1997
International Journal of Impotence Research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.44; hybrid open access; APC about USD 4,790; median 139 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly easy; 206 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Journal of Impotence Research is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sexual function and dysfunction studies, Hormonal and reproductive studies and Sexuality, Behavior, and Technology, together about 57.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Established in 1989, our highly respected journal publishes ground-breaking work, including the first research on Viagra (Sildenafil). We cover the study of sexual dysfunction, addressing sexual medicine for all sexes and genders as an interdisciplinary field. We also publish numerous special features, including Wilson's Workshop, and welcome comments and reviews focusing on key topics. We ensure high visibility for your publication through the nature.com platform. We also provide guidance to authors on how to expand the reach of their work through repositories and our free SharedIt initiative. We offer funder-compliant open access options.
From the journal's Aims & Scope
Research area (LetPub): Urology & Nephrology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sexual function and dysfunction studiesMedicine31.4%
- Hormonal and reproductive studiesMedicine16.3%
- Sexuality, Behavior, and TechnologyPsychology9.7%
- Genital Health and DiseaseMedicine8.6%
- Urinary Bladder and Prostate ResearchMedicine8.3%
- Sexual Differentiation and DisordersBiochemistry, Genetics and Molecular Biology3%
- Urological Disorders and TreatmentsMedicine2.8%
- Female Genital Mutilation/Cutting IssuesMedicine2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCurrent ContentsPublisher website
Other: Index Medicus
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.44LetPub ·
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.6Publisher website ·
- CiteScore 2026-06
- 6LetPub ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 1.24LetPub ·
- h-index
- 77LetPub ·
- h-index
- 106OpenAlex ·
- i10-index
- 1,589OpenAlex ·
- 2-year mean citedness
- 2.26OpenAlex ·
- Self-citation rate
- 24%LetPub ·
- Share of gold OA articles
- 27.66%LetPub ·
Volume
- Articles per year
- 131LetPub ·
- Downloads per year (publisher) 2025
- 1,483,778Publisher website ·
Articles by year OpenAlex count · 3,190 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 139 | 41 | 51 |
| 2025 | 206 | 74 | 410 |
| 2024 | 197 | 68 | 765 |
| 2023 | 155 | 45 | 931 |
| 2022 | 156 | 51 | 1,726 |
| 2021 | 114 | 33 | 1,487 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
139 daysMedian, submission to acceptance · P25–P75 61 days – 219 days
- Acceptance to online
- median 15 days (98 articles)
- Submission to online
- median 156 days
- Sample
- 98 articles with submission and acceptance dates (381 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,690 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1997
- ISSN
- 0955-9930
- Electronic ISSN
- 1476-5489
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about International Journal of Impotence Research
What CAS zone is International Journal of Impotence Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Impotence Research is in Zone 3 of Medicine, and in Zone 3 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Impotence Research?
The latest impact factor listed by LetPub is 2.44; CiteScore 6, h-index 106.
How long does peer review take at International Journal of Impotence Research?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 61–219 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index International Journal of Impotence Research?
According to LetPub and DOAJ records, International Journal of Impotence Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.
Is International Journal of Impotence Research open access, and what is the APC?
International Journal of Impotence Research is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .